BACKGROUND: The purpose of this study was to evaluate the acute in vivo pump performance of a unique valveless, sensorless, pulsatile, continuous-flow total artificial heart (CFTAH) that passively self-balances left and right circulations without electronic intervention. METHODS: The CFTAH was implanted in two calves, with pump and hemodynamic data recorded at baseline over the full range of pump operational speeds (2,000 to 3,000 rpm) in 200-rpm increments, with pulsatility variance, and under a series of induced hemodynamic states created by varying circulating blood volume and systemic and pulmonary vascular resistance (SVR and PVR). RESULTS: Sixty of the 63 induced hemodynamic states in Case 1 and 73 of 78 states in Case 2 met our design goal of a balanced flow and maximum atrial pressure difference of 10 mm Hg. The correlation of calculated vs measured flow and SVR was high (R(2) = 0.857 and 0.832, respectively), allowing validation of an additional level of automatic active control. By varying the amplitude of sinusoidal modulation of the speed waveform, 9 mm Hg of induced pulmonary and 18 mm Hg of systemic arterial pressure pulsation were achieved. CONCLUSIONS: These results validated CFTAH self-balancing of left and right circulation, induced arterial flow and pressure pulsatility, accurate calculated flow and SVR parameters, and the performance of an automatic active control mode in an acute, in vivo setting in response to a wide range of imposed physiologic perturbations. Copyright (c) 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
BACKGROUND: The purpose of this study was to evaluate the acute in vivo pump performance of a unique valveless, sensorless, pulsatile, continuous-flow total artificial heart (CFTAH) that passively self-balances left and right circulations without electronic intervention. METHODS: The CFTAH was implanted in two calves, with pump and hemodynamic data recorded at baseline over the full range of pump operational speeds (2,000 to 3,000 rpm) in 200-rpm increments, with pulsatility variance, and under a series of induced hemodynamic states created by varying circulating blood volume and systemic and pulmonary vascular resistance (SVR and PVR). RESULTS: Sixty of the 63 induced hemodynamic states in Case 1 and 73 of 78 states in Case 2 met our design goal of a balanced flow and maximum atrial pressure difference of 10 mm Hg. The correlation of calculated vs measured flow and SVR was high (R(2) = 0.857 and 0.832, respectively), allowing validation of an additional level of automatic active control. By varying the amplitude of sinusoidal modulation of the speed waveform, 9 mm Hg of induced pulmonary and 18 mm Hg of systemic arterial pressure pulsation were achieved. CONCLUSIONS: These results validated CFTAH self-balancing of left and right circulation, induced arterial flow and pressure pulsatility, accurate calculated flow and SVR parameters, and the performance of an automatic active control mode in an acute, in vivo setting in response to a wide range of imposed physiologic perturbations. Copyright (c) 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Authors: Jack G Copeland; Richard G Smith; Francisco A Arabia; Paul E Nolan; Gulshan K Sethi; Pei H Tsau; Douglas McClellan; Marvin J Slepian Journal: N Engl J Med Date: 2004-08-26 Impact factor: 91.245
Authors: Kiyotaka Fukamachi; David J Horvath; Alex L Massiello; Hideyuki Fumoto; Tetsuya Horai; Santosh Rao; Leonard A R Golding Journal: J Heart Lung Transplant Date: 2009-09-26 Impact factor: 10.247
Authors: Jack G Copeland; Richard G Smith; Francisco A Arabia; Paul E Nolan; Douglas McClellan; Pei H Tsau; Gulshan K Sethi; Raj K Bose; Mary E Banchy; Diane L Covington; Marvin J Slepian Journal: J Heart Lung Transplant Date: 2004-07 Impact factor: 10.247
Authors: W C DeVries; J L Anderson; L D Joyce; F L Anderson; E H Hammond; R K Jarvik; W J Kolff Journal: N Engl J Med Date: 1984-02-02 Impact factor: 91.245
Authors: Robert D Dowling; Laman A Gray; Steven W Etoch; Hillel Laks; Daniel Marelli; Louis Samuels; John Entwistle; Greg Couper; Gus J Vlahakes; O H Frazier Journal: J Thorac Cardiovasc Surg Date: 2004-01 Impact factor: 5.209
Authors: David Horvath; Jamshid H Karimov; Nicole Byram; Barry Kuban; Leonard A R Golding; Nader Moazami; Kiyotaka Fukamachi Journal: ASAIO J Date: 2015 Nov-Dec Impact factor: 2.872
Authors: Kiyotaka Fukamachi; Akira Shiose; Alex Massiello; David J Horvath; Leonard A R Golding; Sangjin Lee; Randall C Starling Journal: Ann Thorac Surg Date: 2012-12-25 Impact factor: 4.330
Authors: Akira Shiose; Kathleen Nowak; David J Horvath; Alex L Massiello; Leonard A R Golding; Kiyotaka Fukamachi Journal: ASAIO J Date: 2010 Sep-Oct Impact factor: 2.872
Authors: Jun Feng; William E Cohn; Steven M Parnis; Neel R Sodha; Richard T Clements; Nicholas Sellke; O Howard Frazier; Frank W Sellke Journal: J Surg Res Date: 2015-06-18 Impact factor: 2.192
Authors: Mariko Kobayashi; David J Horvath; Nicole Mielke; Akira Shiose; Barry Kuban; Mark Goodin; Kiyotaka Fukamachi; Leonard A R Golding Journal: Artif Organs Date: 2012-07-02 Impact factor: 3.094
Authors: Jason A Cook; Keyur B Shah; Mohammed A Quader; Richard H Cooke; Vigneshwar Kasirajan; Kris K Rao; Melissa C Smallfield; Inna Tchoukina; Daniel G Tang Journal: J Thorac Dis Date: 2015-12 Impact factor: 2.895